Ratings by Chardan (Globa Amusa)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/27/2022 | 4D Pharma PLC | LBPS | Downgrade | Neutral (Buy) |
1.65 (1.65) |
0% | Details | |
| 9/20/2021 | Forte Biosciences Inc. | FBRX | Upgrade | Neutral (Sell) |
3.60 (44.15) |
1126.39% | Details | |
| 9/3/2021 | Forte Biosciences Inc. | FBRX | Downgrade | Sell (Buy) |
29.92 (44.15) |
47.56% | Details | |
| 4/19/2021 | 4D Pharma PLC | LBPS | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2021 | Forte Biosciences Inc. | FBRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2020 | Forte Biosciences Inc. | FBRX | Upgrade | Buy (Neutral) |
26.69 (44.15) |
65.42% | Details |
